Specialty Injectables Relying Increasingly on Autoinjectors for Delivery and Differentiation

(Amherst, NH) – As injectables for chronic conditions have proliferated, devices that can be prefilled have become the primary device class for branded products. Until recently, the prefilled injection devices segment has been dominated by two major types - prefilled syringes and pen injectors, which combined for more than 80% of devices in this category on a unit basis in 2012.

In the past three years, autoinjectors – pen-like devices that can accept standard prefilled syringes and simplify the injection event for patients - have emerged as a major drug delivery platform. The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. These market factors foretell positive market dynamics for autoinjectors for the remainder of the decade.

Suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices – devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass. They will have to compete – in some cases head-on – with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharma customer requirements for product-specific syringe designs.

The evolving autoinjector market is detailed in a new and comprehensive report researched and written by Greystone Research Associates. Autoinjectors to 2022 analyzes the global market for autoinjectors by therapeutic market, device class and competitor. The report analyzes demand drivers, development factors, market considerations, and strategic and economic factors, and provides profiles of market sector participants.

More information is available at http://www.greystoneassociates.org

Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.